Superbug

Regretfully, goodbye.

Let me tell you a little story about my first husband. We met when I was in graduate school. He was a foreign journalist working in America and I interned where he worked. I left town, finished my degree, moved back. We reconnected, got married, and were considered enough of a catch — two sharp…

Hiatus: Yeah, me too.

I’m taking SUPERBUG offline while the Pepsi mess plays out. I dislike and resent having to do this: I was flattered to join Sb and I have great respect for my Sciblings. I acknowledge that Sb’s management, Seed Media Group, made some concessions today, but I am dissatisfied that those changes came only after community…

Pepsi: Messy.

I’m late to the party: I was in Europe, and before that I was in Los Angeles, and before that Colorado, and I am time-shifted and sleep-deprived (hate it: Takes away energy, intellectual nimbleness — yeah, I got some – and any ability to multi-task). And that’s enough with the lame excuses. Constant readers may have…

(You leave the country for a few days — I spoke at a conference in Brussels, which was was lovely, thanks for asking — and all kinds of news breaks out. So, sorry to be late on this, but it’s an important issue.) Last week, the Food and Drug Adminstration took the first (baby, mincing,…

In the winter of 1999, I stood in an outpatient clinic in a pediatric hospital in New Delhi and listened to a father sobbing over the paralysis of his only son. He was a farmer and lived in Uttar Pradesh; counting walks, minibuses and trains, it had taken him 24 hours to get to the…

There’s a troubling item in this afternoon’s issue of the CDC’s Morbidity and Mortality Weekly Report or MMWR: The first report in the United States of a novel resistance mechanism that renders gram-negative bacteria extremely drug-resistant and that has been linked to medical care carried out in India or Pakistan. The short item describes three…

In case anyone’s in the general vicinity of the Twin Cities this week: On Tuesday night, I’ll be discussing antibiotic use in US agriculture at Fair Food Fight Night (a regular event sponsored by the food-policy blog Fair Food Fight) with Thom Petersen of the Minnesota Farmers Union and Fair Food Fight’s proprietor, novelist and…

A set of papers published this month in two journals provide an unsettling glimpse into the rocketing incidence and complex epidemiology of one really scary pathogen, Acinetobacter baumanii. In the all-star annuals of resistant bugs, A. baumanii is an underappreciated player. If people — other than, you know, disease geeks — recognize it, that is…

The Center for Global Development, a DC think-tank, is releasing what looks like a thoughtful report aimed at refocusing policy debates over drug resistance toward the epidemic’s global impact, with particular attention to the the developing world.

Bad news: From MRSA to LRSA

Via the Journal of the American Medical Association, a report from Spain: the first recorded outbreak, in a Madrid hospital, of Staphylococcus aureus resistant to linezolid (Zyvox), one of only a few drugs still available to treat very serious infections of drug-resistant staph, MRSA. This is bad news. Background: The M in MRSA stands for…